1st International consensus guidelines for advanced breast cancer (ABC 1)

被引：274

作者：

Cardoso, F. ^{[1
,2
]}

Costa, A. ^{[3
]}

Norton, L. ^{[4
]}

Cameron, D. ^{[5
,6
]}

Cufer, T.

Fallowfield, L. ^{[7
]}

Francis, P. ^{[8
]}

Gligorov, J. ^{[9
]}

Kyriakides, S. ^{[10
]}

Lin, N. ^{[11
]}

Pagani, O. ^{[12
,13
]}

Senkus, E. ^{[14
]}

Thomssen, C. ^{[15
]}

Aapro, M. ^{[16
]}

Bergh, J. ^{[17
]}

Di Leo, A. ^{[18
]}

El Saghir, N. ^{[19
]}

Ganz, P. A. ^{[20
]}

Gelmon, K. ^{[21
]}

Goldhirsch, A. ^{[22
]}

Harbeck, N. ^{[23
]}

Houssami, N. ^{[24
]}

Hudis, C. ^{[25
]}

Kaufman, B. ^{[26
]}

Leadbeater, M. ^{[27
]}

Mayer, M. ^{[28
]}

Rodger, A.

Rugo, H. ^{[29
]}

Sacchini, V. ^{[30
]}

Sledge, G. ^{[31
]}

van't Veer, L. ^{[32
]}

Viale, G. ^{[33
]}

Krop, I. ^{[34
]}

Winer, E. ^{[34
]}

机构：

[1] European Sch Oncol, Lisbon, Portugal

[2] Champalimaud Canc Ctr, Breast Unit, Lisbon, Portugal

[3] European Sch Oncol, IT & Bellinzona, Milan, Switzerland

[4] Mem Sloan Kettering Canc Ctr, Breast Canc Program, New York, NY 10021 USA

[5] Univ Edinburgh, Edinburgh, Midlothian, Scotland

[6] Western Gen Hosp, NHS Lothian, Edinburgh EH4 2XU, Midlothian, Scotland

[7] Univ Sussex, Brighton & Sussex Med Sch, Falmer, England

[8] Peter MacCallum Canc Inst, Div Canc Med, Melbourne, Vic 3000, Australia

[9] Univ Paris 05, Francilian Breast Intergrp Paris, CancerEst APHP Tenon, F-75270 Paris 06, France

[10] Europa Donna Cyprus, Nicosia, Cyprus

[11] Dana Farber Canc Inst, Breast Oncol Ctr, Boston, MA 02115 USA

[12] Oncol Inst So Switzerland, Bellinzona, Switzerland

[13] Breast Unit So Switzerland, Bellinzona, Switzerland

[14] Med Univ Gdansk, Dep Oncol & Radiotherapy, Gdansk, Poland

[15] Univ Halle Wittenberg, Klinikum Krollwitz, Clin Gynaecol, Halle, Saale, Germany

[16] Inst Multidisciplinaire Oncol, Div Oncol, Genolier, Switzerland

[17] Karolinska Inst, Dep Oncol Pathol, Stockholm, Sweden

[18] Osped Misericordia & Dolce, Prato, Italy

[19] Amer Univ Beirut, Med Ctr, NK Basile Canc Inst Breast Ctr Excellence, Beirut, Lebanon

[20] Jonsson Comprehens Canc Ctr, Div Canc Prevent & Control Res, Los Angeles, CA 90034 USA

[21] BC Canc Agcy, Vancouver, BC, Canada

[22] European Inst Oncol, Dep Med, Milan, Italy

[23] Univ Munich, Brustzentrum, Munich, Germany

[24] Univ Sydney, Screening & Test Evaluat Program, Sch Publ Hlth, Sydney Med Sch, Sydney, NSW 2006, Australia

[25] Mem Sloan Kettering Canc Ctr, Breast Canc Med Serv, New York, NY 10021 USA

[26] Chaim Sheba Med Ctr, Tel Hashomer, Israel

[27] Breast Canc Care, London, England

[28] AdvancedBC Org, New York, NY USA

[29] UCSF Helen Diller Family Comprehens Canc Ctr, Dept Med, Breast Oncol Program, San Francisco, CA USA

[30] Mem Sloan Kettering Canc Ctr, Breast Serv, New York, NY 10021 USA

[31] Indiana Univ, Med Ctr, Indianapolis, IN USA

[32] UCSF Helen Diller Family Comprehens Canc Ctr, Breast Oncol Program, San Francisco, CA USA

[33] Univ Milan, I-20122 Milan, Italy

[34] Dana Farber Canc Inst, Breast Oncol Ctr, Boston, MA 02115 USA

来源：

BREAST | 2012年 / 21卷 / 03期

关键词：

Advanced breast cancer; Metastatic breast cancer; Guidelines; Consensus; ABC; 1; BRAIN RADIATION-THERAPY; QUALITY-OF-LIFE; STEREOTACTIC RADIOSURGERY; AROMATASE INHIBITOR; 1ST-LINE TREATMENT; PHASE-III; SINGLE METASTASES; LOW-RESOURCE; CHEMOTHERAPY; SURVIVAL;

D O I：

10.1016/j.breast.2012.03.003

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

The 1st international Consensus Conference for Advanced Breast Cancer (ABC 1) took place on November 2011, in Lisbon. Consensus guidelines for the management of this disease were developed. This manuscript summarizes these international consensus guidelines. (C) 2012 Elsevier Ltd. All rights reserved.

引用

页码：242 / 252

页数：11

共 112 条

[1] Guidance on the use of bisphosphonates in solid tumours:: recommendations of an international expert panel [J].

Aapro, M. ;

Abrahamsson, P. A. ;

Body, J. J. ;

Coleman, R. E. ;

Colomer, R. ;

Costa, L. ;

Crino, L. ;

Dirix, L. ;

Gnant, M. ;

Gralow, J. ;

Hadji, P. ;

Hortobagyi, G. N. ;

Jonat, W. ;

Lipton, A. ;

Monnier, A. ;

Paterson, A. H. G. ;

Rizzoli, R. ;

Saad, F. ;

Thuerlimann, B. .

ANNALS OF ONCOLOGY, 2008, 19 (03) :420-432

[2] 2010 update of EORTC guidelines for the use of granulocyte-colony stimulating factor to reduce the incidence of chemotherapy-induced febrile neutropenia in adult patients with lymphoproliferative disorders and solid tumours [J].

Aapro, M. S. ;

Bohlius, J. ;

Cameron, D. A. ;

Dal Lago, Lissandra ;

Donnelly, J. Peter ;

Kearney, N. ;

Lyman, G. H. ;

Pettengell, R. ;

Tjan-Heijnen, V. C. ;

Walewski, J. ;

Weber, Damien C. ;

Zielinski, C. .

EUROPEAN JOURNAL OF CANCER, 2011, 47 (01) :8-32

[3] Metastatic spinal cord syndromes: Imaging appearances and treatment planning [J].

Abdi, S ;

Adams, CI ;

Foweraker, KL ;

O'Connor, A .

CLINICAL RADIOLOGY, 2005, 60 (06) :637-647

[4] Optimisation of breast cancer management in low-resource and middle-resource countries: executive summary of the Breast Health Global Initiative consensus, 2010 [J].

Anderson, Benjamin O. ;

Cazap, Eduardo ;

El Saghir, Nagi S. ;

Yip, Cheng-Har ;

Khaled, Hussein M. ;

Otero, Isabel V. ;

Adebamowo, Clement A. ;

Badwe, Rajendra A. ;

Harford, Joe B. .

LANCET ONCOLOGY, 2011, 12 (04) :387-398

[5] Phase III Randomized Study Comparing Docetaxel Plus Trastuzumab With Vinorelbine Plus Trastuzumab As First-Line Therapy of Metastatic or Locally Advanced Human Epidermal Growth Factor Receptor 2-Positive Breast Cancer: The HERNATA Study [J].

Andersson, Michael ;

Lidbrink, Elisabeth ;

Bjerre, Karsten ;

Wist, Erik ;

Enevoldsen, Kristin ;

Jensen, Anders B. ;

Karlsson, Per ;

Tange, Ulla B. ;

Sorensen, Peter G. ;

Moller, Susanne ;

Bergh, Jonas ;

Langkjer, Sven T. .

JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (03) :264-271

[6] Breast cancer with synchronous metastases: Trends in survival during a 14-year period [J].

Andre, F ;

Slimane, K ;

Bachelot, T ;

Dunant, A ;

Namer, M ;

Barrelier, A ;

Kabbaj, O ;

Spano, JP ;

Marsiglia, H ;

Rouzier, R ;

Delaloge, S ;

Spielmann, M .

JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (16) :3302-3308

[7] Whole brain radiation therapy with or without stereotactic radiosurgery boost for patients with one to three brain metastases: phase III results of the RTOG 9508 randomised trial [J].

Andrews, DW ;

Scott, CB ;

Sperduto, PW ;

Flanders, AE ;

Gaspar, LE ;

Schell, MC ;

Werner-Wasik, M ;

Demas, W ;

Ryu, J ;

Bahary, JP ;

Souhami, L ;

Rotman, M ;

Mehta, MP ;

Curran, WJ .

LANCET, 2004, 363 (9422) :1665-1672

[8]

[Anonymous], J NATL CANC I

[9]

[Anonymous], 2000, EUR J CANCER, V36, P2288

[10]

[Anonymous], NCCN CLIN PRACT GUID

← 1 2 3 4 5 6 7 8 9 10 →